nach oben

Erschienen in:

01.12.2009 | Review

Interventions to improve adherence and persistence with osteoporosis medications: a systematic literature review

verfasst von: T. Gleeson, M. D. Iversen, J. Avorn, A. M. Brookhart, J. N. Katz, E. Losina, F. May, A. R. Patrick, W. H. Shrank, D. H. Solomon

Erschienen in: Osteoporosis International | Ausgabe 12/2009

Einloggen, um Zugang zu erhalten

Abstract

Summary

Adherence and persistence with osteoporosis medications are poor. We conducted a systematic literature review of interventions to improve adherence and persistence with osteoporosis medications. Seven studies met eligibility requirements and were included in the review. Few interventions were efficacious, and no clear trends regarding successful intervention techniques were identified. However, periodic follow-up interaction between patients and health professionals appeared to be beneficial.

Introduction

Adherence and persistence with pharmacologic therapy for osteoporosis are suboptimal. Our goal was to examine the design and efficacy of published interventions to improve adherence and persistence.

Methods

We searched medical literature databases for English-language papers published between January 1990 and July 2008. We selected papers that described interventions and provided results for control and intervention subjects. We assessed the design and methods of each study, including randomization, blinding, and reporting of drop-outs. We summarized the results and calculated effect sizes for each trial.

Results

Seven studies met eligibility requirements and were included in the review. Five of the seven studies provided adherence data. Of those five studies, three showed a statistically significant (p ≤ 0.05) improvement in adherence by the intervention group, with effect sizes from 0.17 to 0.58. Five of the seven studies provided persistence data. Of those five, one reported statistically significant improvement in persistence by the intervention group, with an effect size of 0.36.

Conclusions

Few interventions were efficacious, and no clear trends regarding successful intervention techniques were identified in this small sample of studies. However, periodic follow-up interaction between patients and health professionals appeared to be beneficial.

Nur mit Berechtigung zugänglich

National Osteoporosis Foundation, America's bone health: the state of osteoporosis and low bone mass in our nation. Available at http://nof.org/advocacy/prevalence/index.htm, accessed 12/15/2008. 2008.

United Nations, D.o.E.a.S.A., Population and Division, World Population Prospects: The 2006 Revision, Highlights, Working Paper No. ESA/P/WP.202. 2007.

Burge R et al (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res 22(3):465–475CrossRefPubMed

Cole Z, Dennison E, Cooper C (2008) Update on the treatment of post-menopausal osteoporosis. Br Med Bull 86:129–143CrossRefPubMed

Chapurlat RD, Delmas PD (2006) Drug insight: bisphosphonates for postmenopausal osteoporosis. Nat Clin Pract Endocrinol Metab 2(4):211–219; quiz following 238CrossRefPubMed

Cummings SR et al (1998) Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. Jama 280(24):2077–2082CrossRefPubMed

Black DM et al (1996) Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 348(9041):1535–1541CrossRefPubMed

Harris ST et al (1999) Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. Jama 282(14):1344–1352CrossRefPubMed

Reginster J et al (2000) Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporos Int 11(1):83–91CrossRefPubMed

10.

Chesnut IC et al (2004) Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res 19(8):1241–1249CrossRef

11.

Cranney A et al (2002) Meta-analyses of therapies for postmenopausal osteoporosis IX: summary of meta-analyses of therapies for postmenopausal osteoporosis. Endocr Rev 23(4):570–578CrossRefPubMed

12.

Kothawala P et al (2007) Systematic review and meta-analysis of real-world adherence to drug therapy for osteoporosis. Mayo Clin Proc 82(12):1493–1501CrossRefPubMed

13.

Haynes RB et al (2008) Interventions for enhancing medication adherence. Cochrane Database Syst Rev (2):CD000011

14.

Cadarette SM et al (2007) Psychometric properties of the “Osteoporosis and You” questionnaire: osteoporosis knowledge deficits among older community-dwelling women. Osteoporos Int 18(7):981–989CrossRefPubMed

15.

Werner P (2005) Knowledge about osteoporosis: assessment, correlates and outcomes. Osteoporos Int 16(2):115–127CrossRefPubMed

16.

Giangregorio L et al (2008) Do patients perceive a link between a fragility fracture and osteoporosis? BMC Musculoskelet Disord 9:38CrossRefPubMed

17.

Cramer JA et al (2008) Medication compliance and persistence: terminology and definitions. Value Health 11(1):44–47PubMed

18.

Jadad AR et al (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17(1):1–12CrossRefPubMed

19.

Moher D et al (1995) Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists. Control Clin Trials 16(1):62–73CrossRefPubMed

20.

Cohen J (1987) Statistical power analysis for the behavioral sciences. L Erlbaum Associates, Hillsdale, NJ

21.

Cuddihy MT et al (2004) A prospective clinical practice intervention to improve osteoporosis management following distal forearm fracture. Osteoporos Int 15(9):695–700CrossRefPubMed

22.

Majumdar SR et al (2007) Persistence, reproducibility, and cost-effectiveness of an intervention to improve the quality of osteoporosis care after a fracture of the wrist: results of a controlled trial. Osteoporos Int 18(3):261–270CrossRefPubMed

23.

Shu ASM, Polinski J, Jan S, Patel M, Truppo C, Breiner C, Chen Y, Weiss T, Solomon DH (2009) Adherence to Osteoporosis Medications After Patient and Physician Education: A Post-Hoc Analysis of a Randomized Controlled Trial. American Journal of Managed Care (in press)

24.

Cooper A, Drake J, Brankin E (2006) Treatment persistence with once-monthly ibandronate and patient support vs. once-weekly alendronate: results from the PERSIST study. Int J Clin Pract 60(8):896–905CrossRefPubMed

25.

Delmas PD et al (2007) Effect of monitoring bone turnover markers on persistence with risedronate treatment of postmenopausal osteoporosis. J Clin Endocrinol Metab 92(4):1296–1304CrossRefPubMed

26.

Guilera M et al (2006) Does an educational leaflet improve self-reported adherence to therapy in osteoporosis? The OPTIMA study. Osteoporos Int 17(5):664–671CrossRefPubMed

27.

Cook PF, Emiliozzi S, McCabe MM (2007) Telephone counseling to improve osteoporosis treatment adherence: an effectiveness study in community practice settings. Am J Med Qual 22(6):445–456CrossRefPubMed

28.

Schousboe JT et al (2005) Education and phone follow-up in postmenopausal women at risk for osteoporosis: effects on calcium intake, exercise frequency, and medication use. Dis Manag Health Outcomes 13(6):395–404CrossRef

29.

Clowes JA, Peel NFA, Eastell R (2004) The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: a randomized controlled trial. J Clin Endocrinol Metab 89(3):1117–1123CrossRefPubMed

30.

Rossini M et al (2006) Determinants of adherence to osteoporosis treatment in clinical practice. Osteoporos Int 17(6):914–921CrossRefPubMed

31.

Balkrishnan R (1998) Predictors of medication adherence in the elderly. Clin Ther 20(4):764–771CrossRefPubMed

32.

Rollnick S, Miller W (1995) What is motivational interviewing? Behav Cogn Psychother 23:325–334CrossRef

33.

DiIorio C et al (2008) Using motivational interviewing to promote adherence to antiretroviral medications: a randomized controlled study. AIDS Care 20(3):273–283CrossRefPubMed

34.

Golin CE et al (2006) A 2-arm, randomized, controlled trial of a motivational interviewing-based intervention to improve adherence to antiretroviral therapy (ART) among patients failing or initiating ART. J Acquir Immune Defic Syndr 42(1):42–51CrossRefPubMed

35.

Schmaling KB et al (2001) A randomised controlled pilot study of motivational interviewing to change attitudes about adherence to medications for asthma. J Clin Psychol Med Settings 8(3):167–172CrossRef

36.

Ogedegbe G et al (2008) A practice-based trial of motivational interviewing and adherence in hypertensive African Americans. Am J Hypertens 21(10):1137–1143CrossRefPubMed

Titel: Interventions to improve adherence and persistence with osteoporosis medications: a systematic literature review
verfasst von: T. Gleeson
M. D. Iversen
J. Avorn
A. M. Brookhart
J. N. Katz
E. Losina
F. May
A. R. Patrick
W. H. Shrank
D. H. Solomon
Publikationsdatum: 01.12.2009
Verlag: Springer-Verlag
Erschienen in: Osteoporosis International / Ausgabe 12/2009
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-009-0976-0

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen.
» Jetzt entdecken

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Summary

Introduction

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2009

Lifestyle predicts falls independent of physical risk factors

Peripheral arterial disease and osteoporosis in older adults: the Rancho Bernardo Study

Calcium supplement and bone loss

Calcium supplementation for older men and women?

The prevalence of significant left–right hip bone mineral density differences among black and white women